🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Introducing the CRISP technique…. Coils are frequently used for therapeutic graft closure to reduce competitive flow following native vessel intervention. Stable deployment of coils can be challenging with a risk of migration/embolization particularly if the graft is patent and

Truly humbled and grateful for providing top-quality medical care in our community in Ashland OH at UH Samaritan. Grateful for the opportunity to serve and make a positive impact every day. #UH UH Harrington Heart & Vascular Institute University Hospitals Mehdi Shishehbor, DO uhgiving.org/why-give/givin…

First-in-human percutaneous transseptal Retrieveal of Embolized TRanscatheter valve In the lEft VEntricle (RETRIEVE) Now in press in JACC CVI Thank you to the patient/family and the Morristown team for the trust and support in me for this great save. Philippe Genereux

In this STS/ACC/TVT registry analysis, although overall 30-day all-cause mortality after #mTEER was low (3.0%), 2 of 5 deaths occurred out-of-hospital after discharge. Read more about out-of-hospital mortality after mTEER in this recent #JACCINT paper: jacc.org/doi/10.1016/j.…

World Premiere: first commercially approved transseptal mitral valve at Universitätsmedizin Mainz - the SAPIEN M3 TMVR - many more patients in the future. 🚀#PCR Mitral Focus Group Univ.-Prof. Dr. Ralph Stephan von Bardeleben AGIK Deutsche Gesellschaft für Kardiologie Edoardo Zancanaro MD Erik Rafflenbeul European Society of Cardiology Journals Holger Thiele

Congrats Philipp Lurz and team! Another option for our MR patients. Can’t wait to use it and see it live at one of the upcoming PCR Valves meeting🤩. So much to learn ! PCRonline 🫀 #PCRLV #PCRMitralFocusGroup

MV surgery after failed M-TEER is a high-risk procedure w/ higher-than-expected 30-day mortality. Compared to repair, replacement is assoc w/ a higher 1-yr mortality & a lower 2-yr survival. jacc.org/doi/10.1016/j.… #JACCINT #TEER Mateo Marín-Cuartas Dr. Gilbert Tang Syed Zaid, MD

In this large, propensity-matched cohort of TAVI patients, only invasively measured postprocedural aortic gradients—not echocardiography-derived gradients—were independently associated with 30-day, 1- and 2-year mortality. These results suggest that invasive assessment may

Coronary cannulation post #TAVR with Evolut FX+ facilitated by the larger windows which allow for easier mobilization of catheters CANNULATE TAVR II. Yohei Turi Ohno Mehdi Shishehbor, DO Vinicius Esteves,MD PhD FESC Anene Ukaigwe Marco Frazzetto Dr. Gilbert Tang UH Harrington Heart & Vascular Institute University Hospitals sciencedirect.com/science/articl…

Can’t deliver Sentinel during LAAO with appendage thrombus? No big deal… switch to full embolic protection :) ŌNŌCOR Philippe Genereux Pedro Villablanca MD, MSc, FACC, FSCAI Ahmad Jabri MD , FACC, FSCAI Jonathan X Fang, MBBS, FACC, FSCAI Kosta Koulogiannis

New study in #JACCHF on growth hormone (GH) replacement in pts w/ GH deficiency + #HFrEF 🔸 Improved exercise capacity + #QoL in GH replacement vs controls 🔸 Impetus here to screen for GH more, consider in those w/ residual Sx despite #GDMT 📎: jacc.org/doi/10.1016/j.…

1/ Coronary artery obstruction during #TAVR is rare (~0.7%) but deadly. Enter BASILICA: Bioprosthetic or Native Aortic Scallop Intentional Laceration to Prevent Iatrogenic Coronary Artery obstruction. A clever solution to a deadly problem. #CardioTwitter #StructuralHeart

Fantastic work led by superstar BIDMC Smith Center research fellow Katerina Dangas on the uptake of PCI in ambulatory surgical centers in the US and associated outcomes. A featured presentation at SCAI. BIDMC Smith Center Rishi Wadhera, MD MPP Eric Secemsky MD MSc medpagetoday.com/meetingcoverag…

Thank you Daniel I. Simon, M.D. for this great interview and the opportunity to share my professional trajectory and discuss details of our Valve and Structural Heart Center Mehdi Shishehbor, DO Anene Ukaigwe Vinicius Esteves,MD PhD FESC Yohei Turi Ohno Hitesh Raheja Sandeep M Patel, M.D. Hamza Ali Lodhi

Valve-in-valve TAVR is safe and effective for small aortic annuli. A report from a Japanese Nationwide Registry presented PCRonline 🫀 #EuroPCR and published simultaneously Yohei Turi Ohno EuroIntervention #AHAJournals #cardiotwitter ahajrnls.org/45lfFCd

Redo-TAV simulation using post-TAVR CT imaging performed at 30 days suggested higher redo-TAV feasibility in patients with bicuspid aortic valves compared with tricuspid aortic valves. jacc.org/doi/10.1016/j.… #JACCINT #TAVR vinayak bapat

Interested in discovering how the #LateBreaking science presented at #EuroPCR 2025 will impact your practice? Read high-level summaries with top takeaways drafted by SCAI experts ➡️ scai.org/coverage-europ… @PCROnline #InterventionalCardiology

Congrats Abbott Cardiovascular for U.S. FDA approval of #Tendyne #TMVR in MAC pts with mitral valve disease. This will be the first FDA approval of a TMVR device in the US. Thousands of implants have been done worldwide with 3-5y follow up on the longest survivors. Device is transapical

Humbly sharing our work 👇 Intrapleural tissue plasminogen activator and deoxyribonuclease in complex pleural effusion and empyema, clinical outcomes, and predictors - Yub Raj Sedhai, Rodney T. Steff, Karan Singh et al. journals.sagepub.com/doi/10.1177/17…

How long is too long to be performing CPR on patients who suffer in-hospital cardiac arrest? Every patient and situation is obviously different, but it shouldn't come as a surprise that beyond 30 minutes, things don't look too good. 🎩 tip to the authors. eddyjoemd.com/foamed